Progressive supranuclear palsy is a rare condition that affects the brain. The condition is also called Steele-Richardson-Olszewski syndrome. Progressive supranuclear palsy causes the brain cells that ...
- Topline supports moving to Phase 3 trial and shows potential to develop GV1001 as the world's first PSP treatment PSP is a degenerative disease that, like Parkinson's disease, causes symptoms such ...
The recent discovery of a unique protein pattern in spinal fluid may make earlier diagnosis of progressive supranuclear palsy a reality. Researchers at the University of California San Francisco (CA, ...
Rep. Jennifer Wexton (D-VA) announced that she will not seek reelection in 2024 after having been diagnosed with the rare degenerative disorder progressive supranuclear palsy. The 55-year-old ...
Spanish international pharmaceutical company Ferrer has announced the completion of patient recruitment for the PROSPER study ...
ASN90, an O-GlcNAcase inhibitor, is a new chemical entity at clinical stage and a promising candidate for the treatment of PSP, a disorder with a high unmet medical need PSP is a rare neurological ...
In Alzheimer's disease, aggregation of Aβ precedes tau aggregation, but in primary tauopathies, the upstream instigators are shrouded in mystery. A study published May 25 in Science Advances casts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback